Richard K. Matros - 08 Jan 2026 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Signature
/s/ Michael Costa, as Attorney-in-Fact
Issuer symbol
SBRA
Transactions as of
08 Jan 2026
Net transactions value
-$4,391,542
Form type
4
Filing time
12 Jan 2026, 19:07:32 UTC
Previous filing
05 Jan 2026
Next filing
12 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MATROS RICHARD K Chair, CEO and President, Director C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN /s/ Michael Costa, as Attorney-in-Fact 12 Jan 2026 0001184158

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBRA Common Stock Award $0 +319,394 +33% $0.000000 1,286,760 08 Jan 2026 Direct F1
transaction SBRA Common Stock Tax liability $4,391,542 -223,944 -17% $19.61 1,062,816 08 Jan 2026 Direct F2
transaction SBRA Common Stock Gift $0 -232,936 -22% $0.000000 829,880 08 Jan 2026 Direct F3, F4
transaction SBRA Common Stock Gift $0 +232,936 +14% $0.000000 1,857,686 08 Jan 2026 By R&A Matros Revocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 27, 2022, including 67,146 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 8, 2026 that the number of TSR units earned was 200% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested immediately. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock on or about January 2, 2027, subject to earlier payment in the event of death, disability or change of control.
F2 Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person.
F3 Represents shares of the Issuer's Common Stock acquired in connection with the payout of previously vested restricted stock units that have been transferred by the reporting person to the R&A Matros Revocable Trust.
F4 Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.